Topline data from CHAPTER-3, a pivotal study of deucrictibant for prophylactic treatment of HAE attacks, anticipated in 3Q2026Preparation of NDA dossier of deucrictibant for on-demand treatment of HAE ...
Two NDA submissions expected by mid-February 2026 for ulixacaltamide in essential tremor and relutrigine in SCN2A/8A-DEEs, ...
DALTON — Like many rural areas in Massachusetts, the Central Berkshire Regional School District is facing a tough budget ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback